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Significant progress has been made in the last decade in the development of optogenetic
effectors and sensors that can be deployed to understand complex biological signaling
in mammals at a molecular level, without disrupting the distributed, lineage specific
signaling circuits that comprise nuanced physiological responses. A major barrier to the
widespread exploitation of these imaging tools, however, is the lack of readily available
genetic reagents that can be easily combined to probe complex biological processes.
Ideally, one could envision purpose–produced mouse lines expressing optically compatible
sensors and effectors, sensor pairs in distinct lineages, or sensor pairs in discrete
subcellular compartments, such that they could be crossed to enable in vivo imaging
studies of unprecedented scientific power. Such lines could also be combined with
mice to determine the alteration in signaling accompanying targeted gene deletion or
addition. In order to address this lack, the National Heart Lung and Blood Institute
has recently funded an optogenetic resource designed to create optically compatible,
combinatorial mouse lines that will advance NHLBI research. Here we review recent
advances in optogenetic sensor and effectors and describe the rationale and goals for the
establishment of the Cornell/National Heart Lung Blood Resource for Optogenetic Mouse
Signaling (CHROMus).
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INTRODUCTION
Normal and abnormal physiological processes involve dynamic
and highly specific cell signals that occur on a millisecond time
scale. Most of these events are opaque to scientific observation
in real time, however, because molecular scale information about
these events is typically restricted to average measurements at a
single point in time, or the study of reductive, ex vivo prepa-
rations of isolated cells that inadequately represent the more
complex physiological processes of interest. The advent of the use
of re-engineered fluorescent protein sensors and light–activated
channel protein effectors under cell-specific transcriptional con-
trol in genetically modified organisms has enabled a new era of
in vivo biology, in which increasingly powerful molecular detec-
tors and actuators of cellular processes are used to understand
complex biological events in real time, in vivo, in mammals.
The confluence of technological advances in purpose-
engineered sensor and effector proteins, mouse genetics, and
fluorescence imaging has introduced unprecedented opportuni-
ties for the study of complex biological processes in vivo, in
real time, in mammals (Tsien, 2003; Muller-Taubenberger, 2006;
Kotlikoff, 2007; Fenno et al., 2011; Mehta and Zhang, 2011;
Miyawaki, 2011; Tangney and Francis, 2012). Optogenetic tools,
including high gain molecular sensors, and efficiently coupled
light–activated effectors can be used to interrogate complex bio-
logical processes in ways that are not possible with conventional
methods, and parallel advances in bacterial artificial chromosome
(BAC) transgenesis have enabled the production of mice that
express high levels of optical sensors and effectors in a lin-
eage specific manner without disrupting endogenous genetic loci
(Lee et al., 2001). More than a decade of progress on geneti-
cally encoded Ca2+ indicators (Palmer and Tsien, 2006; Kotlikoff,
2007; Zhao et al., 2011; Chen et al., 2013) and light activated opto-
genetic effector proteins derived from bacterial or mammalian
opsins (Deisseroth, 2011; Rein and Deussing, 2012) has resulted
in the creation of a mature set of tools (Figure 1A). Thus, it
is now possible to genetically engineer and cross mouse strains
in which complex systems can be interrogated at a molecular
level in mammals, in real time, in vivo, a requisite capabil-
ity to understand the way that the interaction of millions of
cells are coordinated to produce physiological outputs, or fail
to do so.
The major barrier to the effective use of these technologies
in cardiovascular biology, however, is the lack of mouse lines
designed to probe clinically relevant, complex physiological, and
pathological interactions. In this brief review, we describe a new
resource established by the National Heart, Lung, and Blood
Institute (NIH R24 HL120847-01) to accelerate the adaptation
of these technologies. CHROMus, the Cornell/NHBLI Resource
for Optogenetic Mouse Signaling (chromus.vet.cornell.edu), is
designed to produce combinatorial mouse lines with discrete
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FIGURE 1 | (A) Timeline of development of optogenetic effectors
and sensors. (B) Evolution of GCaMP2 improving basal
fluorescence (F0Ca2+ ) and dynamic range. (C) Improved performance
of GCaMP8 to spike depolarizations in cultured neurons. Images
from Ohkura et al. (2012a) (D) Response of R-GECO1 and
RCaMP1.07 to a single spike. Images from Ohkura et al. (2012b)
(E) Simultaneous imaging with Red and Green GECIs. Images
from Ohkura et al. (2012b).
fluorescent characteristics, creating a library of reagents with
compatible optical properties that can be effectively exploited
for effector/detector and lineage/lineage signaling experiments
relevant to heart, lung, and blood biology.
GENETICALLY ENCODED MOLECULAR SENSORS
Genetically encoded fluorescent sensors that respond dynam-
ically to changes in concentration of cellular molecules have
advanced dramatically since the first sensors were developed
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from fluorescent proteins (Miyawaki et al., 1997, 1999; Nakai
et al., 2001). While the range of detected molecules has steadily
advanced (Newman et al., 2011), the most progress has been
made on genetically encoded Ca2+ indicators, or GECIs, which
have been progressively improved and expanded to additional
wavelengths, lower Ca2+ affinities, and ratiometric molecules
(Zhao et al., 2011; Despa et al., 2014). GECIs measure the key
molecular signal underlying cell functions such as heart, vessel,
and airway contraction, lung secretion, autonomic neurotrans-
mission, and immunocyte function (Clapham, 1995; Berridge
et al., 1999). Thus, these tools enable in vivo and in situ exper-
iments that simply could not be performed using synthetic
reagents such as optical dyes, because of the need for lineage
specificity. Moreover, once germline transmission is achieved, the
degree of expression is consistent and is no longer an exper-
imental variable. This approach has been applied to studies
of cardiovascular, lung, and airway inflammation, cardiac and
smooth muscle electrical and chemical signaling, endothelial bar-
rier function and control of vascular tone, organellar signaling,
tissue repair, and the functional evaluation of stem cell thera-
pies. Mouse lines expressing genetically encoded Ca2+ indicators
(GECIs) in cardiac musle (Tallini et al., 2006a), and endothe-
lium (Tallini et al., 2007) have been used to unravel signaling
critical for cardiac development (Tallini et al., 2006a), vascu-
lar control (Tallini et al., 2007; Ledoux et al., 2008; Bagher
et al., 2011; Sonkusare et al., 2012, 2014), and cardiac cell ther-
apy (Roell et al., 2007; Shiba et al., 2012), but the limited
number of these lines has limited adaption of the technology.
The lack of these reagents relates to several factors: they are
time consuming and expensive to produce, require technology
that is often not present in typical labs, and are difficult to
justify on a single grant. In this brief chapter, we describe a
recently funded NHLBI resource designed to address this lack
by the creation of approximately 50 lines of mice in which
third-generation genetic Ca2+ sensors and optogenetic effectors
are specified in lineages relevant to cardiac, vascular, lung, and
blood diseases.
GCaMPs and RCaMPs: GCaMP sensors constitute a robust
platform of 3rd generation sensors with high gain, and variable
gain and Ca2+ affinity (Nakai et al., 2001; Tallini et al., 2006a;
Tian et al., 2009; Muto et al., 2011; Zhao et al., 2011; Despa
et al., 2014). Structural and biophysical studies of GCaMP2 indi-
cate that the Ca2+ -dependent fluorescence occurs through a
Ca2+/Calmodulin -dependent de-protonation of the fluorophore
that has been destabilized and rendered vulnerable to hydration
and protonation by the circular permutation of EGFP (Wang
et al., 2008). In the protonated state (e.g. at low pH), the fluo-
rophore has an absorbance peak at 395 nm, and minimal absorp-
tion and fluorescence at 488 nm excitation; circular permutation
of the original EGFP results in an almost completely protonated
fluorophore at physiological pH. However, Ca2+ binding to the
fused calmodulin domain of GCaMPs eliminates proton (water)
access to the fluorophore, resulting in a rapid deprotonation and
an attendant spectroscopic shift to bright fluorescence at 488 nm
excitation. Structural analysis indicates that the phenolic oxygen
in GCaMP2- Ca2+ is stabilized in the anionic state through the
formation of hydrogen bonds with Thr-116 and Ser-118(Wang
et al., 2008). Thus, GCaMP molecules that are not Ca2+ bound
have an absorbance maximum of 399nm and shift rapidly to
488 nm absorption upon Ca2+ binding.
GCaMPs have also been markedly improved since the devel-
opment of GCaMP2 (Tallini et al., 2006a) (Figures 1B,C), which
itself was an improvement in the stability and dynamic range
of the original GCaMP1(Nakai et al., 2001), and enabled the
first in vivo Ca2+ measurements in a transgenic mouse line
(Tallini et al., 2006a). Three additional mutations in GCaMP2
(M153K, T203V in eGFP, and N60D in calmodulin) produced
GCaMP3, with higher brightness at Ca2+ saturation and a
somewhat higher dynamic range than GCaMP2 (Tian et al.,
2009). Recently Campbell’s laboratory identified several muta-
tions through a large scale mutational screen in bacteria, leading
to G-GECO1, which has an increased dynamic range, but some
loss of brightness (Zhao et al., 2011). Over the past year two addi-
tional significant improvements have been reported. Akerboom
et al. conducted an extensive structure-guided analysis, lead-
ing to improvements in the dynamic range of GCaMP3; several
GCaMP5s were reported, including GCaMP5G, which improves
the dynamic range of GCaMP3 almost 3 fold while decreasing
minimum brightness only modestly (Akerboom et al., 2012).
Experiments from Nakai’s laboratory introduced EGFP super-
folding mutations in GCaMP2, producing GCaMP-HS (Muto
et al., 2011), and used site directed and randommutations to pro-
duce GCaMP6, GCaMP7, and GCaMP8 (Ohkura et al., 2012a).
GCaMP5G and GCaMP8 are the highest dynamic range GCaMPs
developed to date (F/F0 = 32.7 and 37.5, respectively), with
GCaMP8 having a modestly higher dynamic range and more
rapid off-kinetics, but less brightness at basal Ca2+, an issue
that is of less concern in stable transgenic lines with consistent
expression.
Red–shifted indicators provide an important advantage to
GCaMPs in the context of determining cell-cell signaling, and
when partnered with rhodopsins whose excitation spectra over-
lap with GCaMPs. Important advances in red–shifted indicators
have also been made. Zhao et al. circularly permutated mApple
and conducted a bacterial screen that finally resulted in R-GECO1
(Zhao et al., 2011). This red–shifted indicator has a distinct
spectrum relative to GCaMPs, a 16 fold dynamic range, and
brightness that exceeds GCaMP2. R-GECO1 has been improved
to R-CaMP1.07 by Nakai’s group with an F/F0 of 28.7 and
slightly higher brightness (Ohkura et al., 2012b) (Figure 1D).
Importantly, the spectrum of R-CaMPs is compatible with chan-
nel rhodopsins. Green and red GCaMPs have discrete spectra and
can be effectively used in dual imaging experiments (Figure 1E).
Moreover, GCaMP8 and RCaMP1.07 have very similar kDs
(∼200 nM), facilitating combinatorial experiments.
We have recently created a ratiometric GCaMP, GCaMP-
GR for green/red, by fusing mCherry to the c-terminus of
a high signal GCaMP. The advantages of this approach are
that signals can be quantitated and experiments can be tar-
geted by visualizing the bright mCherry expression in cells that
have low GCaMP fluorescence at resting Ca2+. As shown in
Figure 2A, GCaMP-GR, combines the GCaMP3 alaninemutation
in calmodulin as well as the M153T, and K203V EGFP muta-
tions that convert GCaMP2 to GCaMP3 (Akerboom et al., 2012),
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FIGURE 2 | (A) Ratiometric GCaMP, GCaMP-GR, was created by fusing an
improved GCaMP (GCaMP3 with the additional mutations shown) with
mCherry, using an optimized linker. Below Ca2+ -dependent green
fluorescence of GCaMP-GR protein relative to earlier GCaMPs. The Fmax/F0
ratio is improved in GCaMP-GR due to a lower F0 fluorescence. (B) Targeting
of GCaMP-GR in mice. Top, a smooth muscle actin bacterial artificial
chromosome (ACTA2BAC) construct was used to target GCaMP-GR. Middle,
smooth muscle–specific green and red fluorescence in vascular smooth
muscle, anti-GFP IHC staining. Bottom, green and red fluorescence in
smooth muscle of small intestine. (C) CHROMus, the Cornell Heart, Lung,
Blood Resource for Optogenetic Mouse Signaling, which will create
combinatorial mouse strains.
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with the four EGFP superfolding mutations that were separately
made in GCaMP2 to produce GCaMP-HS (Muto et al., 2011).
The resulting GCaMP has a lower resting fluorescence and higher
dynamic range than GCaMP3, with a roughly equivalent KD for
Ca2+ (Figure 2A). We fused mCherry to this sensor to combine
bright, Ca2+ -independent mCherry fluorescence, enabling easy
detection of expressing cells, thereby obviating the problem of
minimal GCaMP fluorescence at low Ca2+, and enabling ratio-
metric measurements. The linker after the calmodulin sequence
at the c-terminus of GCaMP was systematically varied to main-
tain full GCaMP dynamic range as well as mCherry brightness.
The best result was obtained with a flexible alanine-proline repeat
linker (GSSTSG-APAPAPAPAPAPAP-SEF) and GCaMP-GR dis-
plays a slightly higher gain that the original modified GCaMP.
We used this sensor to create a ratiometric GCaMP-GR mouse,
in which GCaMP-GR is placed within an ACTA2 bacterial arti-
cifical chromosome and is highly expressed in smooth muscle
(Figure 2B). High intensity red fluorescence completely overlaps
with green fluorescence, enabling quantitative measurements.
GENETICALLY ENCODED OPTICAL EFFECTORS
Optogenetic effectors, or light–activated effector proteins, repre-
sent a parallel, and complementary set of tools, enabling targeted
cell activation (Boyden et al., 2005; Miller, 2006; Wang et al.,
2007; Fenno et al., 2011; Rein and Deussing, 2012). Similar to
genetically encodable Ca2+ sensors, these cell actuators can be
expressed in a targeted fashion, enabling the activation of dis-
crete biological events, and now comprise a mature and diverse
set of tools that enable the activation of a broad array of cel-
lular processes and have advanced to a palette of color-tuned
tools. Light–gated channel proteins that depolarize and activate
cells have proved to be a major advantage in the study of neu-
ral circuits (Boyden et al., 2005; Wang et al., 2007; Witten et al.,
2010; Zhang et al., 2010; Lammel et al., 2012; Lee et al., 2012;
Narayanan et al., 2012; Warden et al., 2012; Chaudhury et al.,
2013; Tye et al., 2013). The applicability of optogenetic effec-
tors has been advanced by the development of fusion products
between rhodopsins and G-protein coupled receptors (GPCR);
activation of a broad range of “non-excitable” cells is possible
through the triggered generation of second messengers (Airan
et al., 2009; Gradinaru et al., 2010). Genetic specification of these
proteins, combined with the chronic implantation of fiber-optic
bundles, enables chronic experiments that reveal complex adapta-
tions within the nervous system (Ung and Arenkiel, 2012; Wang
et al., 2012), but also extends the potential utility of these tools
to the study of other complex biological processes. The optoge-
netic effector tool kit now includes channelrhodopsin-2 (ChR2),
a 489 nm activated cation channel that depolarizes and activates
excitable cells (Zhang et al., 2006), and the rhodopsin/adrenergic
receptor fusion proteins opto-α1AR and opto-β2AR, which gen-
erate the intracellular 2nd messengers InsP3/DAG and cAMP,
respectively (Airan et al., 2009). As with GCaMPs, optogenetic
effectors have been progressively improved, with structurally
guided modifications of ChR1 and ChR2 resulting in a lower light
activation threshold and increased current outputs (Kleinlogel
et al., 2011; Prigge et al., 2012; Lin et al., 2013; Dawydow et al.,
2014; Pan et al., 2014).
Moreover, light–activated hyperpolarizing proton pumps
mediate cell silencing, extending the range of effective circuit
interrogations (Chow et al., 2010). Rhodopsin–based tools are
particularly well suited to pairing with red–shifted detectors such
as RCaMP1.07, as excitation of the effectors occurs in the range
of 480–500 nm and RCaMP1.07 or R-GECO1 are not excited by
the effector stimulus. Conversely, the excitation of rhodopsins
overlaps with that of the EGFP–based GCaMPs, resulting in
an inability to terminate rhodopsin activation while monitoring
GCaMP signals. Blue and red–shifted channelrhodopsins have
been developed that decrease, but do not eliminate, the activa-
tion of effectors by the excitation of GCaMP fluorescence (Prigge
et al., 2012). In practice, the rapid activation and desensitization
of optogenetic effectors may enable the use of lineage specified
rhodopsin proteins with GCaMP–based detectors, despite the
spectral overlap, but the pairing of ChR2 and RCaMP avoids this
problem.
A GENETIC RESOURCE FOR OPTOGENETIC EFFECTORS AND
SENSORS
To date there has been minimal production of mice expressing
optogenetic proteins or GECIs, and no targeted effort to pro-
duce optically compatible, combinatorial lines. Not suprisingly,
most applications have involved viral expression of these proteins,
an approach that has several distinct drawbacks including vari-
able and transient expression in target cells, overexpression that
could alter normal signaling, and the inability to perform combi-
natorial experiments. While a few recombinase-based lines have
been developed (Witten et al., 2011; Zariwala et al., 2012), these
bi-allelic strategies are problematic in that they require compli-
cated crosses, often do not satisfy the stringent requirements of
high expression and tight lineage control, and are not an effec-
tive combinatorial strategy, since expressing four desired alleles
(recombinase plus floxed allele for each optogenetic tool) in a
single animal is too inefficient to be practical. Knock-in strate-
gies also have limitations, as the disruption of multiple gene loci
may result in poorly predictable alterations in normal physiology.
While random insertion of relatively large DNA elements such
as BACs may in some circumstances alter local gene expression,
it is the technique most likely to yield robust, lineage specific
expression in mice that can be simply crossed with other BAC
transgenics. Thus, if effector and detector, or multi-wavelength
approaches are to be pursued, or these technologies are to be
widely deployed in knockout mice, monoallelic lines with strong,
tissue specific expression are required. Our experience to date
indicates that this approach, combined with careful screening,
results in stable lines that can be routinely used as a unique tool to
probe complex systems at a molecular scale (Ji et al., 2004; Tallini
et al., 2006a,b, 2007, 2009, 2014; Roell et al., 2007; Ledoux et al.,
2008; Krasteva et al., 2011; Nausch et al., 2012; Shiba et al., 2012;
Sonkusare et al., 2012; Chong et al., 2014; Sonkusare et al., 2014).
The Cornell/National Heart, Lung, Blood Resource for
Optogenetic Mouse Signaling (CHROMus) seeks to accelerate
the pace at which optogenetic tools (sensors and effectors) are
deployed to explore complex biology and disease by develop-
ing, publicizing, and distributing key lines that can be exploited
by numerous laboratories in different physiological contexts
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(Figure 2C). The Resource will create and validate lineage spe-
cific mouse lines designed for combinatorial use such that the
co-expression of optically compatible effectors and sensors, or the
expression of sensors with discrete emission wavelengths in inter-
acting lineages (e.g., endothelial and smooth muscle cells), can
be achieved with simple, high efficiency crosses. The strategy will
enable the combination of spectrally compatible sensor-sensor,
or sensor/effector, in specific lineages in a manner unachievable
by virally mediated gene transfer. Separate, homozygous lines
of lineage specific expressors can be maintained by individual
laboratories based on their interest, and combined in simple,
high yield breeding strategies, enabling experiments that inter-
rogate complex systems. CHROMus will create and validate 50
mouse lines, communicate their availability, and bank them for
distribution to the scientific community, creating a permanent
optogenetic resource. All mice will be created on an FVB/NJ—
C57BL/2J hybrids and back crossed onto the C57BL/6J strain.
The resource will combine several technical breakthroughs made
over the past few years including the creation of efficient activa-
tors of secondary messengers such as InsP3 and cAMP, brighter
and higher dynamic range GECIs, the creation of high-signal low-
affinity color-shifted GCaMPs, and the advanced transcriptional
control of BAC transgenesis. It will combine these technolo-
gies in a targeted, large-scale manner, enabling investigators to
more easily realize the promise of optogenetic sensor/effector
technology for the investigation of complex biological processes.
The resource will develop the first transgenic animals to express
the new generation of wave-length shifted, affinity–shifted, and
higher gain GECIs, and enable the first systematic combination
of optogenetic effectors and high-signal genetic Ca2+ detectors.
Through the creation, dissemination, and distribution of this
state-of-the art resource of signaling mouse lines, CHROMus
mice will enable experiments that are not currently feasible.
Lines will include those with lineage specific expression of high
gain GECIs with discrete emission wavelengths and tuned Ca2+
affinities, and optogenetic proteins that enable light–activated
cellular depolarization or release of the key second messen-
gers InsP3/diacylglycerol or cAMP. BAC or promoter constructs
expressing Ca2+ and other biosensors, and light–activated recep-
tors (opto-α1AR, opto-β2AR) and channels (ChR2) will be cre-
ated and tested for robust lineage-specific expression. In addition
to producing specified lines that have been chosen for their imme-
diate relevance to NHLBI investigators, we will retain the capacity
to produce additional lines proposed by NHLBI scientists over
the Resource funding period. A Steering Committee with broad
NHLBI expertise will approve these additional lines from requests
solicited from funded investigators. Thus, the proposed resource
will accelerate access to important technologies critical to the
understanding and treatment of diseases relevant to the NHLBI.
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